PharmiWeb Today Story
ICON and Advarra launch connected site network model
ICON and Advarra have formed a partnership to create a connected site network model designed to make clinical trials easier for research sites to run. The agreement links ICON’s trial technology and services with Advarra’s systems already used by many investigators and study teams worldwide.
The companies said this should reduce administrative burden, improve study startup, and help more sites take part in complex trials. They also plan to support emerging research sites with tools that simplify workflows and widen access to studies. For sponsors, the model is intended to provide better visibility into trial progress and improve planning, site selection, patient recruitment, and overall delivery.
Read More...
Articles
Featured Events
-
Pharmaceutical Manufacturing & Packaging Congress…
28-Jun-2021 - 29-Jun-2021 -
HFpEF Drug Discovery & Development Summit 2022
25-Jan-2022 - 27-Jan-2022 -
Reuters Events: Pharma USA 2023
28-Mar-2023 - 29-Mar-2023 -
Global Biomanufacturing Summit
25-May-2023 - 26-May-2023 -
Working in and Around #MedComms
25-Sep-2023 - 25-Sep-2023 -
Pharmaceutical marketing for non-marketers
26-Sep-2023 - 28-Sep-2023
News
-
Sygnature Discovery strengthens in vivo pharmacolo…
25-Mar-2026 -
UCB Selects Georgia for New U.S. Biologics Manufac…
25-Mar-2026 -
NHS Confederation and NHS Providers respond to Int…
25-Mar-2026 -
Clinicians call for streamlining over sophisticati…
25-Mar-2026 -
Sasineprocel’s future lies as a monotherapy in P…
25-Mar-2026 -
Teleradiology Enhances Patient Care Through Faster…
25-Mar-2026
